Recent Developments in the Chiral Chromatography Column Market:

# In January 2020, Thermo Fisher entered into an agreement with Astrea Bioseparations to supply EvolveD columns, which include proprietary CaptureSelect and POROS chromatography resins that have been manufactured by Astrea. The columns and resins are used as a part of the molecule purification process to develop biotherapeutics.

# In March 2019, the company introduced the new Thermo Scientific TriPlus 500 Gas Chromatography Headspace Autosampler that provides a scalable, compact design that is reliable, efficient, and capable of handling samples at high-throughput for pharmaceutical, food safety, and environmental scientists performing regulatory-compliant volatile organic compound (VOC) analysis.

# In January 2018, the company introduced FAME GC columns. Agilent J&W DB-FastFAME GC columns feature a mid-content cyanopropyl phase (USP G48). They are engineered for rapid, selective analysis of saturated and polyunsaturated FAMEs, including challenging cis-trans isomers cis-trans isomers.

Major Growth Boosting Factors:

Market growth is driven largely by factors, such as increasing R&D investments in the pharmaceutical and biotechnology industry, and increasing importance of chromatography tests for drug approvals. Moreover, growth opportunities in emerging countries as well as green chromatography are expected to present avenues of growth for market players.

Restraints: Lack of skilled professionals

The proper use of analytical technologies such as chromatography, PCR, and NGS requires expertise with relevant experience and knowledge. Various technological innovations in the chiral chromatography columns market are increasing the need for skilled professionals who can effectively operate chiral chromatography columns. For instance, an inconsistent column packing can result in low purity levels and product yield, which would, in turn, impact the quality of the final product. Moreover, the selection of the right chromatography technique (specific to a given task) plays a crucial role in the purification process. The lack of knowledge regarding the right choice of technique incurs several direct and indirect expenses and increases the time to market the drugs.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435

COVID-19 Impact on the Global Chiral Chromatography Column Market

The COVID-19 pandemic has intensified drug discovery and research efforts while adding to the pressure on pharma and clinical labs. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is still diverse. While a few industries will register a drop in demand, numerous others will continue to remain stable and show promising growth opportunities. The chiral chromatography columns market has witnessed significant growth over the years; however, due to the unexpected COVID-19 outbreak, the market is expected to witness additional growth in 2020, owing to the increasing use of chromatography techniques in the approval of various drugs. In addition, technological advancements and the increasing importance of chromatography in hospital laboratories, forensic laboratories, and pharmaceutical companies will enhance market growth in the forecast period.

Challenges: Inadequate infrastructure for research in emerging countries

Adequate infrastructure for research, coupled with a skilled workforce, financial support, and basic research laboratories, are the key prerequisites for the use of chiral chromatography techniques for research. However, emerging countries in Asia (such as India, Indonesia, and the Philippines), the Middle East (such as Oman, Iraq, and UAE), and Africa lack the required infrastructure. For instance, in India, of the 4,168 private laboratories in the state of Kerala, only 7% have the National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation or ISO certification

Opportunities: Growth opportunities in emerging countries

Many developing economies, such as India, China, Brazil, Russia, Taiwan, and South Korea, offer high-growth opportunities for major market players in the life science instrumentation market owing to the increasing growth opportunities for analytical instruments. Although the adoption of advanced technologies is low in developing countries, their huge population base and increasing research activities, especially in India and China, are expected to offer a sustainable market for life science instruments. Furthermore, with the increasing number of greenfield projects and rising capital expenditure on infrastructure development, these countries are offering potential growth avenues for market players

End Users:

By the end-user, the pharmaceutical & biotechnology companies segment is expected to make the most significant contribution to the chiral chromatography column market during the forecast period.

Pharmaceutical and biotechnology companies are among the key end users of chiral chromatography columns. They use analytical instrumentation during various stages of biopharmaceutical and pharmaceutical drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435

Geographical Growth Dynamics:

North America is expected to be the largest market during the forecast period.

US and Canada are the major countries considered for the study of the chiral chromatography column market. North America has a diverse and well-established R&D infrastructure, with rapid adoption of chromatography techniques among end-user industries. North America accounted for the largest share of 37.3% of the chiral chromatography columns market in 2019. A number of factors, such as increasing drug development activities, the availability of government funding for life science R&D, high adoption of technologically advanced solutions, and a large number of ongoing clinical research studies are driving the growth of the North American chiral chromatography columns market.